Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack T Seki

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Annals of Pharmacotherapy|November 28, 2002
CNS relapses of acute promyelocytic leukemia after all-trans retinoic acidLisa D Burry, Jack T Seki
Journal of Clinical Medicine Research|September 9, 2015
Lenalidomide Desensitization in Systemic Light-Chain Amyloidosis With Multi-Organ InvolvementJack T Seki, Naoko Sakurai, Vishal Kukreti
Current Oncology (Toronto, Ont.)|June 25, 2026
Thrombosis-Associated Risk Factors in Pediatrics and Adults Treated with Asparaginase-Containing Chemotherapy for ALL: A Systematic Review and Meta-AnalysisJack T Seki, Eshetu G Atenafu, Hassan Sibai
British Journal of Haematology|January 7, 2022
Prophylaxis with low-molecular-weight heparin reduces thrombotic events and allows continuation of asparaginase containing regimens during intensification phaseHassan Sibai, Eshetu G Atenafu, Jack T Seki
International Journal of Pharmaceutics|August 22, 2020
The pharmaceutical stability of trastuzumab after short-term storage at room temperature assessed by analytical techniques and tumour imaging by microSPECT/CTConrad Chan, Jack T Seki, R Kwong, et al.
Leukemia Research Reports|April 30, 2026
Gilteritinib-associated hand-foot syndrome: a novel dermatologic reaction in refractory FLT3 Acute myeloid leukemiaJack T Seki, Jad Sibai, Maria Agustina Perusini, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 9, 2008
Acute renal failure, gastrointestinal bleeding, and cardiac arrhythmia after administration of arsenic trioxide for acute promyelocytic leukemiaRichard Cashin, Lisa Burry, Kenneth Peckham, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2012
Desensitization to lenalidomide in a patient with relapsed multiple myelomaJack T Seki, Sabiha Banglawala, Emily M Lentz, et al.
Journal of Clinical Medicine Research|July 21, 2017
Recurrent Body Rash Warranted Second Desensitization With Acyclovir in a Myeloma Patient: A Case ReportJack T Seki, Pamela Ng, Wallace Lam, et al.
Journal of Thrombosis and Thrombolysis|November 3, 2019
Universal venous thromboembolism policy is effective but may not adequately protect hospitalized cancer patients with larger BMIAnna Xu, Hassan Sibai, Eshetu G Atenafu, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Annals of Pharmacotherapy|November 28, 2002
CNS relapses of acute promyelocytic leukemia after all-trans retinoic acidLisa D Burry, Jack T Seki
Journal of Clinical Medicine Research|September 9, 2015
Lenalidomide Desensitization in Systemic Light-Chain Amyloidosis With Multi-Organ InvolvementJack T Seki, Naoko Sakurai, Vishal Kukreti
Current Oncology (Toronto, Ont.)|June 25, 2026
Thrombosis-Associated Risk Factors in Pediatrics and Adults Treated with Asparaginase-Containing Chemotherapy for ALL: A Systematic Review and Meta-AnalysisJack T Seki, Eshetu G Atenafu, Hassan Sibai
British Journal of Haematology|January 7, 2022
Prophylaxis with low-molecular-weight heparin reduces thrombotic events and allows continuation of asparaginase containing regimens during intensification phaseHassan Sibai, Eshetu G Atenafu, Jack T Seki
International Journal of Pharmaceutics|August 22, 2020
The pharmaceutical stability of trastuzumab after short-term storage at room temperature assessed by analytical techniques and tumour imaging by microSPECT/CTConrad Chan, Jack T Seki, R Kwong, et al.
Leukemia Research Reports|April 30, 2026
Gilteritinib-associated hand-foot syndrome: a novel dermatologic reaction in refractory FLT3 Acute myeloid leukemiaJack T Seki, Jad Sibai, Maria Agustina Perusini, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 9, 2008
Acute renal failure, gastrointestinal bleeding, and cardiac arrhythmia after administration of arsenic trioxide for acute promyelocytic leukemiaRichard Cashin, Lisa Burry, Kenneth Peckham, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2012
Desensitization to lenalidomide in a patient with relapsed multiple myelomaJack T Seki, Sabiha Banglawala, Emily M Lentz, et al.
Journal of Clinical Medicine Research|July 21, 2017
Recurrent Body Rash Warranted Second Desensitization With Acyclovir in a Myeloma Patient: A Case ReportJack T Seki, Pamela Ng, Wallace Lam, et al.
Journal of Thrombosis and Thrombolysis|November 3, 2019
Universal venous thromboembolism policy is effective but may not adequately protect hospitalized cancer patients with larger BMIAnna Xu, Hassan Sibai, Eshetu G Atenafu, et al.
Pageof 3